Impella ECP
Showing 1 - 25 of 128
High-Risk Percutaneous Coronary Intervention Trial (Impella ECP)
Recruiting
- High-Risk Percutaneous Coronary Intervention
- Impella ECP
-
Detroit, MichiganAscension St. John Hospital
Dec 23, 2022
High-risk Percutaneous Coronary Intervention Trial in Boston, Detroit, Cincinnati (Impella ECP)
Recruiting
- High-risk Percutaneous Coronary Intervention
- Impella ECP
-
Boston, Massachusetts
- +3 more
Jun 27, 2022
V-A ECMO AUTO Mode Registry
Not yet recruiting
- Heart Failure
- V-A ECMO AUTO Mode algorithm
-
Aachen, NRW, GermanyUniklinik RWTH Aachen
Mar 6, 2023
Impella in Cardiogenic Shock Registry
Recruiting
- Shock, Cardiogenic
- Treatment with impella device.
-
Leuven, BelgiumUniversity Hospitals Leuven, Gasthuisberg
Aug 22, 2023
Patients Using Sodium Bicarbonate
Not yet recruiting
- Cardiogenic Shock
- High Risk PCI
- Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
- Impella RP with Sodium Bicarbonate used as purge solution
- (no location specified)
Apr 20, 2023
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
The Influence of Extracorporeal Photopheresis on Skin Sclerosis
Completed
- Scleroderma, Systemic
- +4 more
-
Berlin, GermanyCharité-Universitätsmedizin Berlin
Nov 16, 2022
ST-segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock Trial (Impella CP®, Standard of Care)
Not yet recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- Cardiogenic Shock
- Impella CP®
- Standard of Care
- (no location specified)
Aug 16, 2022
Left Ventricular Dysfunction, Coronary Artery Disease Trial in Worldwide (Impella CP® / Impella CP® with SmartAssist® / Impella
Recruiting
- Left Ventricular Dysfunction
- Coronary Artery Disease
- Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
- IABP Intra-aortic balloon pump
-
Birmingham, Alabama
- +104 more
Aug 11, 2022
Left Ventricular Dysfunction Trial in Aachen, Hamburg (Device: Impella 5.5 with SmartAssist)
Not yet recruiting
- Left Ventricular Dysfunction
- Device: Impella 5.5 with SmartAssist
-
Aachen, NRW, Germany
- +1 more
Mar 6, 2023
Extracorporeal Photopheresis in Sezary Syndrome
Recruiting
- Sezary Syndrome
- Extracorporeal photopheresis (ECP)
- Methoxsalen Injection
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Aug 12, 2022
Heart Failure, Acute Decompensated Heart Failure Trial in Evanston (Impella BTR)
Recruiting
- Heart Failure
- Acute Decompensated Heart Failure
- Impella BTR
-
Evanston, IllinoisNorthwestern University
May 23, 2022
SURPASS Impella 5.5 Study
Recruiting
- Cardiogenic Shock
- Acute Decompensated Heart Failure
- Impella 5.5
-
Los Angeles, California
- +8 more
Oct 18, 2022
Medical Condition Requiring Extracorporeal Organ Support Trial in Freiburg
Recruiting
- Medical Condition Requiring Extracorporeal Organ Support
-
Freiburg, GermanyUniversity of Freiburg Medical Center
Mar 31, 2023
Cardiogenic Shock Trial in Hamburg (Impella, VA-ECMO)
Recruiting
- Cardiogenic Shock
- Impella
- VA-ECMO
-
Hamburg, GermanyUniversity Heart and Vascular Center Hamburg
Dec 28, 2022
Lung Transplant Infection, Lung Transplant Rejection Trial in Vienna (ECP (Extracorporeal Photopheresis System))
Completed
- Lung Transplant Infection
- Lung Transplant Rejection
- ECP (Extracorporeal Photopheresis System)
-
Vienna, AustriaMedical University Vienna
Jan 31, 2023
Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)
Recruiting
- Immune Related Adverse Events
- +3 more
-
Freiburg, Baden-Württemberg, GermanyMedical Center - University of Freiburg Albert-Ludwigs-Universit
Jun 9, 2022
COVID-19 Trial in Budapest (Extracorporeal photopheresis)
Recruiting
- COVID-19
- Extracorporeal photopheresis
-
Budapest, HungarySouth Pest Central Hospital, National Institute of Haematology a
May 28, 2023
ECP Combination Study
Active, not recruiting
- Steroid Refractory GVHD
- Ruxolitinib
- +2 more
-
Antwerp, Belgium
- +37 more
Jun 17, 2022
Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)
Recruiting
- Type 1 Diabetes
- ECP regular-intensity arm
- +2 more
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
Oct 28, 2022
ST Elevation (STEMI) Myocardial Infarction of Anterior Wall Trial in Worldwide (Impella CP® placement prior to reperfusion with
Recruiting
- ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
- Impella CP® placement prior to reperfusion with Primary PCI
-
Birmingham, Alabama
- +69 more
Jan 20, 2023
Cardiogenic Shock Trial in Philadelphia (Interscalene Block, PECS II Block, Superficial Cervical Plexus Block)
Not yet recruiting
- Cardiogenic Shock
- Interscalene Block
- +2 more
-
Philadelphia, Pennsylvania
- +1 more
Mar 22, 2023
Cardiogenic Shock Trial in Switzerland
Recruiting
- Cardiogenic Shock
-
Basel, Switzerland
- +4 more
Feb 23, 2022
Impella Supported OPCABG
Recruiting
- Ischemic Cardiomyopathy
- Impella 5.0 and Impella 5.5 with SmartAssist Supported OPCABG
-
Milwaukee, WisconsinThe Medical College of Wisconsin
May 18, 2022
Intestinal Biomarker Analysis After ECP for ICI Colitis
Recruiting
- Colitis
- Immune Checkpoint Inhibitor-Related Colitis
- Intestinal tissue analysis
-
Freiburg, Baden Württemberg, GermanyFreiburg University Medical Center
Oct 5, 2023